Ferenc Fenyvesi

Dr. Ferenc Fenyvesi

Department of Molecular and Nanopharmaceutics, University of Debrecen, Faculty of Pharmacy, Debrecen, Hajdú-Bihar, Hungary
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2010 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
TKT. Kiss
T. Kiss
Ferenc FenyvesiFerenc Fenyvesi
Ferenc Fenyvesi
IBI. Bácskay
I. Bácskay
Judit VáradiJudit Váradi
Judit Váradi
ÉFÉ. Fenyvesi
É. Fenyvesi
MVM. Vecsernyés
M. Vecsernyés

1 October 2012 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
ZUZoltán Ujhelyi
Zoltán Ujhelyi
Ferenc FenyvesiFerenc Fenyvesi
Ferenc Fenyvesi
Judit VáradiJudit Váradi
Judit Váradi
PFPálma Fehér
Pálma Fehér
TKTímea Kiss
Tímea Kiss
IBIldikó Bácskay
Ildikó Bácskay

20 November 2019 in Scientia Pharmaceutica
Verified
Journal Article
Open access
PDF file
Adam HaimhofferAdam Haimhoffer
Adam Haimhoffer
Ágnes RusznyákÁgnes Rusznyák
Ágnes Rusznyák
KRKatalin Réti-Nagy
Katalin Réti-Nagy
Gabor VasvariGabor Vasvari
Gabor Vasvari
Judit VáradiJudit Váradi
Judit Váradi
Ferenc FenyvesiFerenc Fenyvesi
Ferenc Fenyvesi
Cyclodextrins are widely used excipients, composed of glucopyranose units with a cyclic structure. One of their most important properties, is that their inner cavity is hydrophobic, while their surface is hydrophilic. This enables them for the complex formation with lipophilic molecules. They have several applications in the pharmaceutical field like solubility enhancers or the building blocks of larger drug delivery systems. On the other hand, they have numerous effects on cells or biological barriers. In this review the most important properties of cyclodextrins and cyclodextrin-based drug delivery systems are summarized with special focus on their biological activity.

1 September 2016 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
MMMilo Malanga
Milo Malanga
JSJulianna Szemán
Julianna Szemán
Eva FenyvesiEva Fenyvesi
Eva Fenyvesi
IPIstván Puskás
István Puskás
KCKatalin Csabai
Katalin Csabai
LSLajos Szente
Lajos Szente

1 November 2014 in Archives of Medical Research
Verified
Journal Article
Closed access
Miklós VecsernyésMiklós Vecsernyés
Miklós Vecsernyés
Ferenc FenyvesiFerenc Fenyvesi
Ferenc Fenyvesi
IBIldikó Bácskay
Ildikó Bácskay
Maria DeliMaria Deli
Maria Deli
LSLajos Szente
Lajos Szente
ÉFÉva Fenyvesi
Éva Fenyvesi

11 November 2015 in Molecules
Verified
Journal Article
Open access
PDF file
EREszter Róka
Eszter Róka
Zoltán UjhelyiZoltán Ujhelyi
Zoltán Ujhelyi
Maria DeliMaria Deli
Maria Deli
ABAlexandra Bocsik
Alexandra Bocsik
Eva FenyvesiEva Fenyvesi
Eva Fenyvesi
Dr Bácskay Katalin IldikóDr Bácskay Katalin Ildikó
Dr Bácskay Katalin Ildikó
Cyclodextrins, even the 6-membered α-cyclodextrin, are approved in the various pharmacopoeias as pharmaceutical excipients for solubilizing and stabilizing drugs as well as for controlling drug release. Recently α-cyclodextrin has also been marketed as health food with beneficial effects on blood lipid profiles. However, the concentration of α-cyclodextrin used may be very high in these cases, and its toxic attributes have to be seriously considered. The objective of this study was to investigate the cytotoxicity of various, differently substituted α-cyclodextrin derivatives and determine relationship between the structures and cytotoxicity. Three different methods were used, viability tests (MTT assay and Real Time Cell Electronic Sensing on Caco-2 cells) as well as hemolysis test on human red blood cells. The effect of α-cyclodextrin derivatives resulted in concentration-dependent cytotoxicity, so the IC50 values have been determined. Based on our evaluation, the Real Time Cell Electronic Sensing method is the most accurate for describing the time and concentration dependency of the observed toxic effects. Regarding the cytotoxicity on Caco-2 cells, phosphatidylcholine extraction may play a main role in the mechanism. Our results should provide help in selecting those α-cyclodextrin derivatives which have the potential of being used safely in medical formulations.